Skip to content
★ Sign in to follow
CD

Chandra D. Lovejoy

Executive
Sierra Oncology, Inc.Endocyte Inc
Total declarations
33
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (15 ops.)
€517k

Latest filing published 14 Jan 2016 for Sierra Oncology, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
15
Signal history

Chandra D. Lovejoy: trading record in brief

This profile gathers the share dealings of Chandra D. Lovejoy across 2 companies, led by Endocyte Inc and Sierra Oncology, Inc. Between 25 September 2012 and 12 January 2016, the trades on record add up to 33 filings.

On the market, this insider has only sold: 15 sales, €517k in total. Outside the open market, there are 1 share grant and 17 option exercises. So far in 2016, the count stands at no purchases and 2 sales.

Most recently, on 14 January 2016, the filings show an option exercise in Sierra Oncology, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Chandra D. Lovejoy

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations33 total
  • ◇
    SVP of Reg. Affairs & QualityExecutivesSierra Oncology, Inc.
    0SEC
    7,551 sharesCommon StockSEC:0001209191-16-091478:0
  • ▼
    SVP of Reg. Affairs & QualityExecutivesSierra Oncology, Inc.
    170,489 USD18SEC
    15,411 shares@ US$11.062872.0% of flowCommon StockSEC:0001209191-16-091478:1
  • ▼
    SVP of Reg. Affairs & QualityExecutivesSierra Oncology, Inc.
    66,345 USD14SEC
    5,562 shares@ US$11.928228.0% of flowCommon StockSEC:0001209191-16-091478:2
  • ◇
    VP of Regulatory AffairsExecutivesEndocyte Inc
    1,466 USD0SEC
    479 shares@ US$3.06Common StockSEC:0001144204-14-049403:0
  • ◇
    VP of Regulatory AffairsExecutivesEndocyte Inc
    74,550 USD0SEC
    21,000 shares@ US$3.55Common StockSEC:0001144204-14-049403:1
  • ▼
    VP of Regulatory AffairsExecutivesEndocyte Inc
    150,353 USD0SEC
    21,479 shares@ US$7.00Common StockSEC:0001144204-14-049403:2
  • ◆
    VP of Regulatory AffairsExecutivesEndocyte Inc
    0SEC
    6,250 shares0Common StockSEC:0001144204-14-007377:0
  • ◇
    VP of Regulatory AffairsExecutivesEndocyte Inc
    18,697 USD0SEC
    6,130 shares@ US$3.05Common StockSEC:0001144204-13-044095:0
  • ◇
    VP of Regulatory AffairsExecutivesEndocyte Inc
    546 USD0SEC
    215 shares@ US$2.54Common StockSEC:0001144204-13-044095:1
  • ◇
    VP of Regulatory AffairsExecutivesEndocyte Inc
    1,664 USD0SEC
    655 shares@ US$2.54Common StockSEC:0001144204-13-044095:2
  • ▼
    VP of Regulatory AffairsExecutivesEndocyte Inc
    121,030 USD0SEC
    7,000 shares@ US$17.29Common StockSEC:0001144204-13-044095:3
  • ◇
    VP of Regulatory AffairsExecutivesEndocyte Inc
    277 USD0SEC
    109 shares@ US$2.54Common StockSEC:0001144204-13-011286:0
  • ▼
    VP of Regulatory AffairsExecutivesEndocyte Inc
    1,057 USD0SEC
    109 shares@ US$9.70Common StockSEC:0001144204-13-011286:1
  • ◇
    VP of Regulatory AffairsExecutivesEndocyte Inc
    6,079 USD0SEC
    1,993 shares@ US$3.05Common StockSEC:0001144204-13-011286:2
  • ▼
    VP of Regulatory AffairsExecutivesEndocyte Inc
    19,332 USD0SEC
    1,993 shares@ US$9.70Common StockSEC:0001144204-13-011286:3
  • ◇
    VP of Regulatory AffairsExecutivesEndocyte Inc
    272 USD0SEC
    107 shares@ US$2.54Common StockSEC:0001144204-13-004572:0
  • ▼
    VP of Regulatory AffairsExecutivesEndocyte Inc
    1,023 USD0SEC
    107 shares@ US$9.56Common StockSEC:0001144204-13-004572:1
  • ◇
    VP of Regulatory AffairsExecutivesEndocyte Inc
    1,125 USD0SEC
    443 shares@ US$2.54Common StockSEC:0001144204-13-004572:2
  • ▼
    VP of Regulatory AffairsExecutivesEndocyte Inc
    4,235 USD0SEC
    443 shares@ US$9.56Common StockSEC:0001144204-13-004572:3
  • ◇
    VP of Regulatory AffairsExecutivesEndocyte Inc
    5,060 USD0SEC
    1,659 shares@ US$3.05Common StockSEC:0001144204-13-004572:4
  • ▼
    VP of Regulatory AffairsExecutivesEndocyte Inc
    15,860 USD0SEC
    1,659 shares@ US$9.56Common StockSEC:0001144204-13-004572:5
  • ◇
    VP of Regulatory AffairsExecutivesEndocyte Inc
    272 USD0SEC
    107 shares@ US$2.54Common StockSEC:0001209191-12-059660:0
  • ▼
    VP of Regulatory AffairsExecutivesEndocyte Inc
    968 USD0SEC
    107 shares@ US$9.05Common StockSEC:0001209191-12-059660:1
  • ◇
    VP of Regulatory AffairsExecutivesEndocyte Inc
    5,339 USD0SEC
    2,102 shares@ US$2.54Common StockSEC:0001209191-12-059660:2
  • ▼
    VP of Regulatory AffairsExecutivesEndocyte Inc
    19,023 USD0SEC
    2,102 shares@ US$9.05Common StockSEC:0001209191-12-059660:3

25 of 33 declarations